An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study. Issue 7 (July 2017) - Barra, Sergio; Yu, Emma; Khan, Fakhar; Dutka, David; Virdee, Munmohan